- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Ovation Science announced that it has launched its e-commerce website as well as its cannabidiol (CBD) health and wellness line, Invibe MD.
Ovation Science (CSE:OVAT) announced that it has launched its e-commerce website as well as its cannabidiol (CBD) health and wellness line, Invibe MD.
As quoted in the press release:
The website provides US consumers the ability to purchase high quality health and wellness products infused with the benefits of hemp-derived CBD (Cannabidiol).
“We have leveraged our expertise in the pharmaceutical industry to develop highly effective, patent-protected products. We have been eager to launch our InvibeMD.com website and introduce these exceptional CBD products to the US marketplace. Invibe MD is focused on health and wellness, a market that is growing exponentially, especially by consumers that do not want to smoke, vape or eat their cannabis” said Terry Howlett, President of Ovation.
Click here to read the full release.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.